Misoprostol pretreatment expressed a significant elevation in GSH and NO contents and SOD activity to 624.78%, 589.58%, and 580.95%, respectively, in comparison to the gastric ulcer control group. The gene discussed is SOD1; the disease is gastric ulcer.